Schedule of Application Deadlines for Funding Programs

Funding Options

Currently Accepting Applications

COE Community Outreach and Engagement Supplemental Funding

    Deadline: Rolling application

    Donald D. Dorfman Research Award

    November 16, 2023

    To: Holden Comprehensive Cancer Center Members

    On behalf of the HCCC Nominating Committee I am writing to ask for nominations for the Dorfman Award. The Dorfman Award recognizes the best paper published over a two-year period by HCCC members in lymphoma and leukemia research. These can cover the full spectrum from basic, translational, clinical and population sciences, but must be focused on leukemia or lymphoma. Our last award was made in 2019 and this award process subsequently disrupted by COVID. Since we have made the awards every other year, we plan to make 2 awards based on the two best papers published from Jan 1, 2020 to Dec 31, 2023.

    The nominees will be reviewed by the HCCC Nominating Committee. The Senior author the winning papers will be awarded a $25,000 grant to support their research efforts and will be recognized, along with their research team, at an event to be held in 2024.

    Please send a pdf of the paper nominated to Tami Thompson tami-thompson@uiowa.edu by Dec. 31, 2023.

    Best Regards,

    Michael D. Henry, PhD
    Interim Director, Holden Comprehensive Cancer Center at the University of Iowa

    Application deadline is December 31, 2023.

        Not Currently Accepting Applications

          Adolescent and Young Adult (AYA) Cancer Awards

          Adolescent and Young Adult (AYA) Cancer Awards research award which benefits cancer patients diagnosed between 13 to 39 years of age.

          Closed. Deadline was Noon on Monday, November 6, 2023.

          Aiming For A Cure Foundation Grant Opportunity

          Closed. Deadline for Letters of Intent was noon (CST) on Friday, Feb. 14, 2020.
          Closed [for Invited Proposals Only]. Deadline for invited full proposals was Noon (CST) on Thursday, April 30, 2020.

          Diana Benz Seed Grant

          Holden Comprehensive Cancer Center
          Diana Benz Seed Grant guidelines
          Closed.  Application deadline was Noon, Wednesday, May 31, 2023.

          F99/K00 Predoctoral to Postdoctoral Fellowship Transition Award from National Cancer Institute (NCI)

          Closed. Nomination deadline was Sept. 23, 2022.

            High Throughput Screening (HTS) Facility Funding Opportunity

            Closed. Application deadline was noon on Monday, March 1, 2021.

            Iowa Initiative for Artificial Intelligence/Machine Learning (AI/ML) Funding Opportunity

            Closed. Deadline for Statement of Intent was Friday, Nov. 1, 2019

            Holden Comprehensive Cancer Center, Office of Diversity, Equity and Inclusion Research Award

            Closed. Nomination deadline was on Friday, May 5, 2023

            Junior Faculty Seed Grant - HCCC ACS-IRG

            Closed. Deadline was Noon on Wednesday, May 31, 2023

            Lymphoma Specialized Program of Research Excellence (SPORE)

            Developmental Research Program

            Developmental Research Program (DRP) Award 

            Career Enhancement Program

            Career Enhancement Program (CEP) Award 

            Mezhir Awards for Collaborative Research

            The Mezhir Awards for Collaborative Research support the development of multi-investigator team science to address important research questions in cancer. Collaborative Teams must consist of three or more investigators and must include at least one Holden Comprehensive Cancer Center member, and a Holden Comprehensive Cancer Center member must be the team leader. Please see guidelines for full information.

            Closed–letter of intent deadline was noon on Monday, June 3, 2019.

              Pancreatic Cancer Research Funding Opportunity

              Closed. Deadline for Letters of Concept was Noon, Wednesday, Dec. 1, 2021.

              Pipeline Acceleration for Cancer Therapeutics (PACT) initiative

              Closed. Letters of Intent were due by Noon, Friday, Nov. 5, 2021

              Spohnheimer Thyroid Cancer Research Award

              Closed. Deadline for Letters of Intent was Noon (CST) on Friday, May 14, 2021.

              University of Iowa Grant Resources

              University of Iowa Grant Resources

              Check Departmental Training Opportunities

              External Funding Opportunities

              External Funding Opportunities

              NIH Grant Announcements

              Travel Awards

              Vere D. Wenger Travel Award Guidelines

              Vere D. Wenger Travel Awards are available to help defray partial travel expenses from faculty and staff members in all fields (humanities, law, medicine, natural and social sciences, etc.), from all of the Colleges on The University of Iowa campus who present papers at conferences and/or who attend professional meetings which contribute to the knowledge of cancer or for the well-being of cancer patients. The purpose of these funds is to support travel for researchers who have no other source of support for such travel. We require applications be submitted and approved before the meeting has occurred. These awards support travel to all locations in accordance with University of Iowa travel policies. Wenger Travel Awards may also be used to cover registration costs for Conferences and Meetings that will be attended virtually.

              Decisions concerning use of these funds are made by the Leaders of the 4 formal research programs of the HCCC. Inquiries from HCCC members, trainees and staff in need of support to travel to a cancer meeting should be made to the Program Leader most appropriate for the research being supported. HCCC Administration is happy to assist applicants who are unsure about which Program Leader to contact.

              The following will be required before requests will be funded:

              • Information on the dates, location, and sponsorship of the meeting
              • A letter of acceptance of the paper and/or a program listing the presentation
              • An abstract of the paper

              Revised October 2023